CDH1 and gastric cancer: EMT, as evidenced by drastic changes in cell morphology and reversal of the expression of epithelial markers (E-cadherin and β-catenin) and mesenchymal markers (vimentin and fibronectin), was activated in RhoGDI2-overexpressing gastric cancer cells.